文献速递头颈神经MR

形态学MRI联合弥散加权成像在头颈部鳞状细胞癌治疗后淋巴结病变检测中的应用价值

Utility of MRI with morphologic and diffusion weighted imaging in the detection of post-treatment nodal disease in head and neck squamous cell carcinoma.
PubMed 文献 · Eur J Radiol · 2018-02-21

回顾性分析33例头颈部鳞状细胞癌患者,评估形态学MRI联合弥散加权成像(DWIMRI)及表观弥散系数(ADC)测量对治疗后淋巴结复发的诊断效能,以40例颈清扫、133个淋巴结分区、755枚淋巴结的组织病理学为金标准。恶性淋巴结ADCmean低于良性淋巴结(1.15±0.35×10⁻³ mm²/s vs 1.28±0.28×10⁻³ mm²/s,p=.028),最佳ADCmean阈值为1.1695×10⁻³ mm²/s;DWIMRI联合该阈值在不同分析层面均显示高阴性预测值。

要点

  • 恶性淋巴结ADCmean低于良性淋巴结(1.15±0.35×10⁻³ mm²/s vs 1.28±0.28×10⁻³ mm²/s,p=.028)。
  • 鉴别良恶性淋巴结的最佳ADCmean阈值为1.1695×10⁻³ mm²/s。
  • DWIMRI联合形态学标准及ADCmean<1.1695×10⁻³ mm²/s在颈清扫、淋巴结分区及淋巴结层面的阴性预测值分别为100%、90.5%、92.0%。

核心结论

  • DWIMRI无论按颈清扫、淋巴结分区还是按淋巴结分析,均具有高阴性预测值,使其成为治疗后的有用随访工具。

研究设计与样本

  • 回顾性研究,基于33例治疗后怀疑局部区域失败的头颈部鳞状细胞癌患者,行形态学MRI联合弥散加权成像并测量ADC值;以40例颈清扫、133个淋巴结分区、755枚淋巴结的组织病理学 findings 为金标准。

关键影像表现/征象

  • 恶性淋巴结ADCmean为1.15±0.35×10⁻³ mm²/s,良性淋巴结为1.28±0.28×10⁻³ mm²/s(p=.028)。

诊断标准与关键数值

  • DWIMRI联合形态学标准及ADCmean<1.1695×10⁻³ mm²/s的诊断效能:按颈清扫敏感度100%(95%CI 86.2;100)、特异度44.4%(95%CI 15.3;77.3)、阳性预测值86.1%(95%CI 69.7;94.7)、阴性预测值100%(95%CI 39.5;100)。
  • 按淋巴结分区:敏感度83.6%(95%CI 69.7;92.2)、特异度91.6%(95%CI 83.0;96.2)、阳性预测值85.4%(95%CI 71.6;93.4)、阴性预测值90.5%(95%CI 81.7;95.5)。
  • 按淋巴结:敏感度53.1%(95%CI 43.5;62.4)、特异度95.5%(95%CI 93.5;96.9)、阳性预测值67.4%(95%CI 56.6;76.7)、阴性预测值92.0%(95%CI 89.6;93.9)。

临床应用与阅片要点

  • DWIMRI联合ADCmean阈值1.1695×10⁻³ mm²/s在颈清扫、淋巴结分区及淋巴结层面均显示高阴性预测值,可作为治疗后随访工具。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To determine the diagnostic performance of morphologic MRI with diffusion weighted imaging (DWIMRI) for the detection of post-treatment lymph node (LN) recurrence of head and neck squamous cell carcinoma (HNSCC).

METHODS: This retrospective study is based on 33 HNSCC patients who underwent DWIMRI with apparent diffusion coefficient (ADC) measurements for suspected post-treatment loco-regional failure. Two radiologists, blinded to clinical/histopathological data, analyzed MR images according to established morphologic criteria and measured ADC values by drawing regions of interest on each normal/abnormal looking lymph node (LN). Histopathological findings in 40 neck dissections, 133 LN-levels and 755 LNs served as gold standard.

RESULTS: Malignant LNs had lower ADCmean values than benign LNs (1.15 ± 0.35 × 10-3 mm2/s versus 1.28 ± 0.28 × 10-3 mm2/s, p = .028). The optimal ADCmean threshold to differentiate malignant from benign LNs was 1.1695 × 10-3 mm2/s. Sensitivity, specificity, positive (PPV) and negative (NPV) predictive values (95%CI in parentheses) of DWIMRI with morphologic criteria and ADCmean <1.1695 × 10-3 mm2/s were: (a) 100%(86.2;100), 44.4%(15.3;77.3), 86.1%(69.7;94.7), and 100%(39.5;100) per neck dissection; (b) 83.6%(69.7;92.2), 91.6%(83.0;96.2), 85.4%(71.6;93.4), and 90.5%(81.7;95.5) per LN-level; (c) 53.1%(43.5;62.4), 95.5%(93.5;96.9), 67.4%(56.6;76.7), and 92.0%(89.6;93.9) per LN, respectively.

CONCLUSION: The high NPV of DWIMRI irrespective of analysis type (per neck dissection/per neck level/per lymph node) make it a useful follow-up tool after treatment.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Mundada P, Varoquaux AD, Lenoir V, et al. Utility of MRI with morphologic and diffusion weighted imaging in the detection of post-treatment nodal disease in head and neck squamous cell carcinoma. Eur J Radiol. 2018. PMID: 29571791. doi:10.1016/j.ejrad.2018.02.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。